Why is amyloid-β PET requested after performing CSF biomarkers?
author
Groot, Colin
Barkhof, Frederike
van der Flier, Wiesje M.
statement of authorship
Reimand, Juhan, Groot, Colin, Teunissen, Charlotte E., Windhorst, Albert D., Boellaard, Ronald, Barkhof, Frederike, Nazarenko, Sergei, van der Flier, Wiesje M., van Berckel, Bart N.M., Scheltens, Philip, Ossenkoppele, Rik, Bouwman, Femke
publisher
journal volume number month
vol. 73, 2
year of publication
pages
p. 559-569
subject term
keyword
ISSN
1387-2877
notes
Bibliogr.: 32 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
category (general)
category (sub)
kvartiil
TTÜ department
language
inglise
Reimand, J., Groot, C., Teunissen, C.E. et al. Why is amyloid-β PET requested after performing CSF biomarkers? // Journal of Alzheimer's disease (2020) vol. 73, 2, p. 559-569. https://doi.org/10.3233/JAD-190836